[Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317-31.10.1002/jat.2550140502]Search in Google Scholar
[Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000;12:22-37.10.1046/j.1442-2026.2000.00087.x]Search in Google Scholar
[Sheridan RD, Beeson D, Tattersall JEH. Non-competitive block of the human muscle adult nicotinic acetylcholine receptor ion channel by the bispyridinium compounds, SAD-128 (SAD), toxogonin (TOX) and HI-6. Eur J Neurosci 2000;12(Suppl. S):36.]Search in Google Scholar
[Stojiljković MP, Jokanović M. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors. Arh Hig Rada Toksikol 2006;57:435-43.]Search in Google Scholar
[Shih TM, Koviak TA, Capacio BR. Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neurosci Biobehav Rev 1991;15:349-62.10.1016/S0149-7634(05)80028-4]Search in Google Scholar
[Shih TM, McDonough JH, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999;6:86-96.10.1007/BF02256439]Search in Google Scholar
[Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145-54.10.1016/j.tox.2006.11.056]Search in Google Scholar
[Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999;107:233-9.10.1016/S0378-4274(99)00052-1]Search in Google Scholar
[Eto M. Organic and biological chemistry. In: Zweig G, editor. The Organophosphorus Pesticides. Cleveland: CRC Press Inc.; 1976. p. 142.]Search in Google Scholar
[Hamilton MG, Lundy PM. HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 1989;63:144-9.10.1007/BF00316437]Search in Google Scholar
[Maksimović M, Bošković B, Radović L, Tadić V, Deljac V, Binenfeld Z. Antidotal effects of bis-pyridinium-2-monooxime carbonyl derivatives in intoxications with highly toxic organophosphorus compounds. Acta Pharm Jugoslav 1980;30:151-60.]Search in Google Scholar
[Jokanović M, Maksimović M, Kilibarda V, Jovanović D, Savić D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996;85:35-9.10.1016/0378-4274(96)03634-X]Search in Google Scholar
[Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85-96.10.1016/j.tox.2005.11.00316332406]Search in Google Scholar
[Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41-50.10.1016/j.tox.2006.08.01216982122]Search in Google Scholar
[Kovarik Z, Čalić M, Bosak A, Šinko G, Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat Chem Acta 2008;81:47-57.]Search in Google Scholar
[Kovarik Z, Čalić M, Šinko G, Bosak A, Berend S, Lucić Vrdoljak A, Radić B. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 2008;175:173-9.10.1016/j.cbi.2008.04.011]Search in Google Scholar
[Berend S, Lucić Vrdoljak A, Radić B, Kuča K. New bispyridinium oximes: In vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Chem Biol Interact 2008;175:413-6.10.1016/j.cbi.2008.04.031]Search in Google Scholar
[Čalić M, Bosak A, Kuča K, Kovarik Z. Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterases. Chem Biol Interact 2008;175:305-8.10.1016/j.cbi.2008.04.010]Search in Google Scholar
[Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K. Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyi-minomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 2007;50:5514-8.10.1021/jm070653r]Search in Google Scholar
[Kovarik Z, Čalić M, Šinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-oximes. Arh Hig Rada Toksikol 2007;58:201-9.10.2478/v10004-007-0013-7]Search in Google Scholar
[Šinko G, Čalić M, Kovarik Z. para- and ortho-Pyridinium aldoximes in reaction with acetylcholinesterase. FEBS Letters 2006;580:3167-72.10.1016/j.febslet.2006.04.070]Search in Google Scholar
[Šinko G, Čalić M, Bosak A, Kovarik Z. Limitation of the Ellman method: Cholinesterase activity measurement in the presence of oximes. Anal Biochem 2007;370:223-7.10.1016/j.ab.2007.07.023]Search in Google Scholar
[Thompson WR. Use of moving averages and interpolation to estimate median effective dose. Bacteriol Rev 1947;11:115-45.10.1128/br.11.2.115-145.1947]Search in Google Scholar
[Weil CS. Tables for convenient calculation of median-effective dose (LD50 or ED50) and instruction in their use. Biometrics 1952;8:249-63.10.2307/3001557]Search in Google Scholar
[Ellman GL, Courtney KD, Andres VJ, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1960;7:88-95.10.1016/0006-2952(61)90145-9]Search in Google Scholar
[Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Flegenhauer N, Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 1997;16:473-80.10.1177/0960327197016008099292288]Search in Google Scholar
[Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systemic review of clinical trials. Qjm-Mon J Assoc Phys 2002;95:275-83.10.1093/qjmed/95.5.275147592211978898]Search in Google Scholar
[Kalász H, Hasan MY, Sheen R, Kuča K, Petroianu G, Ludányi K, Gergely A, Tekes K. HPLC analysis of K-48 concentration in plasma. Anal Bioanal Chem 2006;385:1062-7.10.1007/s00216-006-0490-616763789]Search in Google Scholar